Th17 cells and Tregs: unlikely allies
- PMID: 24563509
- PMCID: PMC3984971
- DOI: 10.1189/jlb.1213633
Th17 cells and Tregs: unlikely allies
Abstract
Identification of CD4+Foxp3+ Tregs and Th17 modified the historical Th1-Th2 paradigm. Currently, the Th17-Tregs dichotomy provides a dominant conceptual framework for the comprehension of immunity/inflammation and tolerance/immunosuppression in an increasing number of diseases. Targeting proinflammatory Th17 cells or immunosuppressive Tregs has been widely considered as a promising therapeutic strategy in the treatment of major human diseases, including autoimmunity and cancer. The efficacy and safety of such therapy rely on a thorough understanding of immunobiology and interaction of these two subsets of Th cells. In this article, we review recent progress concerning complicated interplay of Th17 cells and Tregs There is compelling evidence that Tregs potently inhibit Th1 and Th2 responses; however, the inhibitory effect of Tregs on Th17 responses is a controversial subject. There is increasing evidence showing that Tregs actually promote the differentiation of Th17 cells in vitro and in vivo and consequently, enhanced the functional consequences of Th17 cells, including the protective effect in host defense, as well as detrimental effect in inflammation and in the support of tumor growth. On the other hand, Th17 cells were also the most potent Th subset in the stimulation and support of expansion and phenotypic stability of Tregs in vivo. These results indicate that these two subsets of Th cells reciprocally stimulate each other. This bidirectional crosstalk is largely dependent on the TNF-TNFR2 pathway. These mutual stimulatory effects should be considered in devising future Th17 cell- and Treg-targeting therapy.
Keywords: Foxp3; IL-17; TNF; TNFR2; immunosuppression; inflammation.
© 2014 Society for Leukocyte Biology.
Figures

Similar articles
-
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.Cytokine. 2014 Jan;65(1):56-64. doi: 10.1016/j.cyto.2013.09.008. Epub 2013 Sep 27. Cytokine. 2014. PMID: 24080164 Free PMC article.
-
IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.J Leukoc Biol. 2014 Jul;96(1):39-48. doi: 10.1189/jlb.1RU0114-010RR. Epub 2014 Apr 17. J Leukoc Biol. 2014. PMID: 24744433 Review.
-
The deviated balance between regulatory T cell and Th17 in autoimmunity.Immunopharmacol Immunotoxicol. 2012 Oct;34(5):727-39. doi: 10.3109/08923973.2011.619987. Epub 2012 Feb 9. Immunopharmacol Immunotoxicol. 2012. PMID: 22316060 Review.
-
The Treg/Th17 paradigm in lung cancer.J Immunol Res. 2014;2014:730380. doi: 10.1155/2014/730380. Epub 2014 Apr 29. J Immunol Res. 2014. PMID: 24872958 Free PMC article. Review.
-
TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.Curr Dir Autoimmun. 2010;11:119-34. doi: 10.1159/000289201. Epub 2010 Feb 18. Curr Dir Autoimmun. 2010. PMID: 20173391 Free PMC article. Review.
Cited by
-
[Pathogenesis of psoriasis].Hautarzt. 2016 Jun;67(6):422-31. doi: 10.1007/s00105-016-3800-8. Hautarzt. 2016. PMID: 27246016 Review. German.
-
Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.PLoS One. 2015 Dec 23;10(12):e0145814. doi: 10.1371/journal.pone.0145814. eCollection 2015. PLoS One. 2015. PMID: 26700881 Free PMC article.
-
The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells.iScience. 2024 Apr 18;27(5):109783. doi: 10.1016/j.isci.2024.109783. eCollection 2024 May 17. iScience. 2024. PMID: 38726369 Free PMC article.
-
Moxibustion and Acupuncture Ameliorate Crohn's Disease by Regulating the Balance between Th17 and Treg Cells in the Intestinal Mucosa.Evid Based Complement Alternat Med. 2015;2015:938054. doi: 10.1155/2015/938054. Epub 2015 Aug 4. Evid Based Complement Alternat Med. 2015. PMID: 26347488 Free PMC article.
-
High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.Cell Mol Life Sci. 2021 Apr;78(8):3987-4002. doi: 10.1007/s00018-021-03808-8. Epub 2021 Mar 13. Cell Mol Life Sci. 2021. PMID: 33715015 Free PMC article.
References
-
- Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357 - PubMed
-
- Sakaguchi S., Yamaguchi T., Nomura T., Ono M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775–787 - PubMed
-
- Belkaid Y., Rouse B. T. (2005) Natural regulatory T cells in infectious disease. Nat. Immunol. 6, 353–360 - PubMed
-
- Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., Chang A., Zou W. (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178, 6730–6733 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials